Judith-Anne W Chapman

Author PubWeight™ 23.48^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.	J Clin Oncol	2008	8.09
2	Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.	J Clin Oncol	2007	6.11
3	Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.	J Clin Oncol	2011	2.58
4	Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.	J Clin Oncol	2009	1.99
5	Effect of quantitative nuclear image features on recurrence of Ductal Carcinoma In Situ (DCIS) of the breast.	Cancer Inform	2008	1.28
6	Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment.	BMC Cancer	2007	0.93
7	Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.	Breast Cancer Res	2014	0.87
8	Avoiding Pitfalls in the Statistical Analysis of Heterogeneous Tumors.	Biomed Inform Insights	2009	0.81
9	Heterogeneity Between Ducts of the Same Nuclear Grade Involved by Duct Carcinoma In Situ (DCIS) of the Breast.	Cancer Inform	2010	0.79
10	Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.	Breast Cancer Res	2013	0.78